✦ LIBER ✦

3–59 Phase III Trial Comparing Doxorubicin Plus Cyclophosphamide With Docetaxel Plus Cyclosphosphamide As Adjuvant Therapy for Operable Breast Cancer

✍ Scribed by Denlinger, C.S.; Goldstein, L.J.

Book ID: 123074644
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 71 KB
Volume: 18
Category: Article
ISSN: 1043-321X
DOI: 10.1016/S1043-321X(07)80360-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase III Trial Comparing Doxorubicin Pl

Phase III Trial Comparing Doxorubicin Plus Cyclophosphamide With Docetaxel Plus Cyclophosphamide As Adjuvant Therapy for Operable Breast Cancer

✍ Jones, S. E.; Savin, M. A.; Holmes, F. A.; O'Shaughnessy, J. A.; Blum, J. L.; Vu 📂 Article 📅 2006 🏛 American Society of Clinical Oncology 🌐 English ⚖ 372 KB

PCN91 LONG TERM COST-EFFECTIVENESS OF DO

PCN91 LONG TERM COST-EFFECTIVENESS OF DOCETAXEL PLUS CYCLOPHOSPHAMIDE COMPARED TO DOXORUBICIN PLUS CYCLOPHOSPHAMIDE AS ADJUVANT TREATMENT FOR WOMEN WITH OPERABLE BREAST CANCER

✍ D Jackson; JM Lee; J Adams; A Gordois 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

S-1 combined with docetaxel following do

S-1 combined with docetaxel following doxorubicin plus cyclophosphamide as neoadjuvant therapy in breast cancer: phase II trial

✍ Moon, Yong; Lee, Soohyeon; Park, Byeong-Woo; Kim, Eun-Kyung; Kim, Seung; Koo, Ja 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 185 KB

Phase III trial of liposomal doxorubicin

Phase III trial of liposomal doxorubicin and cyclophosphamide compared with epirubicin and cyclophosphamide as first-line therapy for metastatic breast cancer

✍ Chan, S. 📂 Article 📅 2004 🏛 Oxford University Press 🌐 English ⚖ 91 KB

Docetaxel and Doxorubicin Compared With

Docetaxel and Doxorubicin Compared With Doxorubicin and Cyclophosphamide as First-Line Chemotherapy for Metastatic Breast Cancer: Results of a Randomized, Multicenter, Phase III Trial

✍ Nabholtz, J.-M. 📂 Article 📅 2003 🏛 American Society of Clinical Oncology 🌐 English ⚖ 150 KB

Myotax: A phase II trial of docetaxel pl

Myotax: A phase II trial of docetaxel plus non-pegylated liposomal doxorubicin as first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclines

✍ E. Curtit; P. Nouyrigat; N. Dohollou; E. Levy; A. Lortholary; J. Gligorov; T. Fa 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 356 KB